KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Account Payables (2017 - 2025)

Historic Change in Account Payables for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to -$2.2 million.

  • Amneal Pharmaceuticals' Change in Account Payables fell 12039.18% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 4305.1%. This contributed to the annual value of $54.4 million for FY2024, which is 45388.14% up from last year.
  • As of Q3 2025, Amneal Pharmaceuticals' Change in Account Payables stood at -$2.2 million, which was down 12039.18% from $6.4 million recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Change in Account Payables high stood at $34.1 million for Q4 2024, and its period low was -$7.2 million during Q2 2021.
  • Over the past 5 years, Amneal Pharmaceuticals' median Change in Account Payables value was $1.7 million (recorded in 2023), while the average stood at $3.5 million.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Change in Account Payables surged by 352666.67% in 2021 and then crashed by 660533.33% in 2022.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Change in Account Payables stood at $1.6 million in 2021, then plummeted by 124.94% to -$407000.0 in 2022, then skyrocketed by 1493.61% to $5.7 million in 2023, then soared by 501.23% to $34.1 million in 2024, then tumbled by 106.41% to -$2.2 million in 2025.
  • Its Change in Account Payables was -$2.2 million in Q3 2025, compared to $6.4 million in Q2 2025 and -$1.1 million in Q1 2025.